IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Asymmetry Capital Management, L.P.

Q4 2016 Holdings

Filed 2017-02-14 | 20 holdings | $3.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bio-Rad Labratories(BIO)COM090572207$3.3M18,31898.5%
PTC Therapeutics(PTCT)COM69366J200$5.3K484,5790.2%
Centene Corp(CNC)COM15135B101$5.1K89,5690.1%
HMS Holdings(HMSY)COM40425J101$4.8K264,7600.1%
Jazz Pharmaceuticals(JAZZ)COMG50871105$4.6K42,5970.1%
ELI Lilly & Co(LLY)COM532457108$4.2K56,9840.1%
Amicus Therapeutics Inc(FOLD)COM03152W109$3.8K756,5960.1%
Synergy Pharmaceuticals IncCOM871639308$3.4K555,0850.1%
Quest Diagnostics(DGX)COM74834L100$2.7K29,4850.1%
Unitedhealth Group Inc(UNH)COM91324P102$2.5K15,6590.1%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$2.4K64,0950.1%
Impax Laboratories IncCOM45256B101$2.2K166,0990.1%
Nevro Corp(NVROEUR)COM64157F103$2.1K28,7250.1%
Incyte Corp(INCY)COM45337C102$2.0K20,3370.1%
Davita(DVA)COM23918K108$1.2K19,4510.0%
Edwards Lifesciences Corp(EW)COM28176E108$95610,2000.0%
Ironwood Pharmaceuticals(IRWD)COM46333X108$87757,3630.0%
Perrigo(PRGO)COMG97822103$86110,3390.0%
Clovis(CLVSEUR)COM189464100$70315,8320.0%
Natera(NTRA)COM632307104$69459,3000.0%